Company: SCAG
Filing Date: 2025-01-06
Form Type: 424B3
Source: 0001213900-25-001215
Chunk: 161

Company: Scage Future
Filing Date: 2025-01-06
Form: 424B3
Chunk 161
---
ated by CSRC on its official website on February 17, 2023, the companies that have already been listed on overseas stock exchanges prior to March 31, 2023 or the companies that have obtained the approval from overseas supervision administrations or stock exchanges for its offering and listing prior to March 31, 2023 and will complete their overseas offering and listing prior to September 30, 2023 are not required to make immediate filings for its listing, but are required to make filings for subsequent offerings in accordance with the Overseas Listing Trial Measures. Companies that have already submitted an application for an initial public offering to overseas supervision administrations but have not yet obtained the approval from overseas supervision administrations or stock exchanges for the offering and listing prior to March 31, 2023 may arrange for the filing within a reasonable time period and should complete the required CSRC filing procedure, the completion of which will be published on the CSRC website, before such companies’ overseas issuance and listing. As advised by PubCo’s PRC counsel, Jingtian & Gongcheng, we will be required to complete the filing with the CSRC for the Business Combination, and the CSRC must have concluded the filing procedure and published the filing results on the CSRC website, prior to the listing of PubCo ADSs and the Assumed Warrants in accordance with the requirements under the Overseas Listing Trial Measures. Scage International designated Nanjing Scage as the domestic responsible entity to file with the CSRC in August 2023 and January 2024 after the filing of the Form 8 -Kannouncing the Business Combination and the submission of the registration statement on Form F -4. As of the date of this proxy statement/prospectus, Scage International and Nanjing Scage are still in the process of, and have not completed, such filing procedures with the CSRC. We may be subject to orders to rectify, warnings and fines or face liability for breach of contractual obligation under the Business Combination Agreement if we fail to comply with the requirements under the Overseas Listing Trial Measures. Scage International will not proceed to complete the Business Combination without receiving CSRC approval pursuant to the Overseas Listing Trial Measures. Regardless of whether this offering will be subject to any filing requirements with the CSRC under the Overseas Listing Trial Measures, any future securities offerings and listings outside of China by our company, including but not limited to follow -onofferings, secondary listings, and going private transactions, will be subject to the filing requirements with the CS